Alembic Pharma Receives U.S. FDA Approval For Breast Cancer Injection
  • last year
#AlembicPharma receives U.S. #FDA's approval for Fulvestrant Injection, which is used in treatment of breast cancer.
CFO Rajkumar Kumar Baheti shares what it means for the company. #BQLive
Recommended